Related Experiment Video
Updated: Jun 9, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
HIVAC (HIV-associated cardiomyopathy): An overlooked complication of HIV in developing countries
Manish Kharel1, Anukul Subedi1, Md Fahad Hossain2
1Kathmandu Medical College Sinamangal Kathmandu Nepal.
Insights
Early treatment for heart failure in HIV patients is vital. Prompt cardiac monitoring in individuals with Human Immunodeficiency Virus (HIV) can prevent severe complications like HIV-associated cardiomyopathy (HIVAC).
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- HIV-associated cardiomyopathy (HIVAC) is a severe complication of Human Immunodeficiency Virus (HIV) infection.
- Pathology has shifted from systolic to diastolic dysfunction with the advent of Antiretroviral Therapy (ART).
- Etiologies vary based on viral load, immune status, ART availability, and socioeconomic factors.
Purpose of the Study:
- To highlight the importance of early cardiac monitoring in HIV patients.
- To present a case of HIVAC in an untreated HIV patient with pulmonary tuberculosis.
Main Methods:
- Case report of a 65-year-old male with untreated HIV.
- Diagnosis of HIV-associated cardiomyopathy and pulmonary tuberculosis.
- Assessment of hemodynamic instability and immune response.
Main Results:
- The patient presented with hemodynamic instability.
- HIVAC was diagnosed, attributed to poor immune response and opportunistic infection (pulmonary TB).
Conclusions:
- Early initiation of Antiretroviral Therapy (ART) and prompt heart failure management are critical for HIV patients.
- Endomyocardial biopsy can guide treatment if resources permit.
- Continuous cardiac monitoring is essential for early detection and prevention of HIVAC progression.
Key Clinical Message:
Early initiation of anti-retroviral treatment and prompt management of heart failure in a AIDS patient is crucial. If resources available endomyocardial biopsy can guide the future management.
Abstract:
HIV-associated cardiomyopathy (HIVAC) is a serious complication of HIV with poorly understood pathology. Systolic dysfunction was a common characteristic of HIVAC which is now replaced as diastolic dysfunction due to the availability of ART. There are various etiologies of HIVAC depending on the degree of viral replication, immune response, availability of ART, and also the disparity between high and low-income countries. We present the case report of a 65-year-old male with a past medical history of untreated HIV who came to the hospital with hemodynamic instability and was diagnosed with HIVAC with pulmonary TB, where the cause of HIVAC was poor immune response and opportunistic infection. Therefore, early cardiac monitoring is essential in HIV patients to prevent its advancement.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

